Regeneron Pharmaceuticals, Inc. (REGN) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases;…
Source: Yahoo Finance
Sector & Industry
Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Regeneron Pharmaceuticals, Inc. at a Glance
| Company | Regeneron Pharmaceuticals, Inc. |
| Ticker | REGN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $827.72 |
| Market cap | $85.22B |
| P/E ratio (trailing) | 20.49 |
| EPS (trailing) | $40.39 |
| 52-week high | $859.34 |
| 52-week low | $541.00 |
| Dividend yield | 0.45% |
| Ex-dividend date | 18 Aug 2026 |
| Beta | 0.19 |
| Return on equity (ROE) | 14.04% |
| Debt-to-equity | 8.54% |
| Average volume | 846,514 |
| Shares outstanding | 101.14M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 15,410 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Frequently Asked Questions
- What is Regeneron Pharmaceuticals, Inc.'s current P/E ratio?
- Regeneron Pharmaceuticals, Inc. (REGN) has a trailing P/E ratio of 20.49 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Regeneron Pharmaceuticals, Inc.'s market capitalisation?
- Regeneron Pharmaceuticals, Inc.'s market cap is $85.22B based on our latest snapshot. See how it ranks by market cap →
- What is REGN's 52-week range?
- Over the past 52 weeks, REGN has traded between $541.00 and $859.34. What does the 52-week range mean? →
- How volatile is Regeneron Pharmaceuticals, Inc. compared to the market?
- Regeneron Pharmaceuticals, Inc. has a beta of 0.19, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Regeneron Pharmaceuticals, Inc. pay a dividend?
- Regeneron Pharmaceuticals, Inc.'s trailing annual dividend yield is 0.45%. Compare with other high-yield stocks →
- What exchange is REGN listed on?
- REGN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Regeneron Pharmaceuticals, Inc. in?
- Regeneron Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →